Cboe Global Markets Posts Record $4.08 Diluted EPS as Third-Quarter Net Revenue Rises 18%

Cboe Global Markets reported Q3 2026 net revenue of $712.2M, up 18% YoY, and record diluted EPS of $4.08. Adjusted diluted EPS rose 36% to $3.63. The company raised 2026 organic revenue growth targets and lowered adjusted operating expense guidance to $830M-$845M. Index options volume increased 24% YoY, and Cboe secured its S&P license through 2051.

Original reporting
Published Oct 30, 2026, 11:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cboe Global Markets Posts Record $4.08 Diluted EPS as Third-Quarter Net Revenue Rises 18% — source image
Decision brief

The 30-second read

$CBOEBullishMed
01

Why it matters

The earnings beat and guidance raise expectations for continued growth in options volume and fee revenue, supporting a bullish outlook for the stock.

02

Market read

Earnings surprise and guidance lift may drive short‑term buying interest in CBOE and related exchange stocks.

03

What to watch

Potential headwinds from regulatory scrutiny of options markets or competition from emerging crypto exchanges.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Cboe Global Markets is a leading U.S. exchange operator; its earnings are closely watched for insights into options trading activity and market liquidity.

Company-level read

Ticker impact

$CBOEBullishHigh confidence
Context

Cboe Global Markets reported record Q3 diluted EPS of $4.08 and 18% revenue growth in its 8‑K filing.

Expected impact

likely upward pressure as the market prices in the earnings beat and higher guidance.

Evidence & confidence

Record EPS, double‑digit revenue growth, and lowered expense guidance are material new data that typically drive price appreciation.

Market effects

Positive earnings may lift other exchange‑operator peers and related fintech services.

U.S. equity markets may see a modest boost from the surprise earnings beat.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If the market had already priced in strong performance, the reaction could be muted or even negative on a sell‑off.

Key entities

  • Cboe Global Markets

    U.S. exchange operator reporting Q3 2026 results.

Related articles

$CBOEMed

CFTC turns Cboe’s own words against it in stock perpetuals lawsuit

The CFTC allowed stock perpetual futures to proceed, then faced a lawsuit from the Capital Markets Alliance (Cboe, Citadel Securities, Healthy Markets Association). The CFTC's defense uses Cboe's past statements and product designs, arguing inconsistency in classification. The alliance's structure and location are also questioned. The case hinges on whether these products are security futures or swaps.

$CMEMed

Trump administration’s embrace of "perp" futures sets off risk alarms for Wall Street stalwarts

The Trump administration's push for perpetual futures (perps) in the US has raised concerns among traditional exchanges like CME Group and Cboe Global Markets, which argue the products are misclassified as futures and pose new risks. Perps, popular in crypto markets, trade 24/7 and can be highly leveraged. The CFTC approved US-listed crypto perps in May, and last week approved single-stock equity perps, sparking lawsuits from incumbent exchanges.

$CBOEMed

Cboe, Citadel Securities and Healthy Markets Sue CFTC Over Stock Perpetuals

Cboe, Citadel Securities, and Healthy Markets sued the CFTC over its approval of perpetual derivatives tied to individual US stocks, arguing they should be classified as security-based swaps under SEC oversight. A judge questioned the CFTC's authority but denied an emergency halt. The case involves KalshiEX, Bitnomial Exchange, and Coinbase Derivatives, with a preliminary injunction request pending.

$CBOEMed

Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC over its approval of single-stock perpetual derivatives. The CMA argues these products should fall under SEC jurisdiction and that the CFTC violated the Administrative Procedure Act. The CMA seeks to vacate the approvals, but a judge denied an emergency restraining order, indicating the CMA may succeed in its claim. The CFTC and CMA are set to respond by November 6 and 10, respectively.

$CBOEMed

Cboe and Citadel Securities Are Suing to Overturn the CFTC’s Approval of Stock Perpetual Futures. Could That Slow Hyperliquid?

Cboe Global Markets (CBOE) and Citadel Securities sued to overturn the CFTC's approval of stock perpetual futures, which Hyperliquid (HYPE) lists outside the U.S. The lawsuit aims to classify these contracts as security-based swaps and halt trading. HYPE's token is trading at $86, down 1.3% in 24 hours but up 7.4% in a week. The lawsuit could impact U.S. exchanges like Coinbase (COIN) and Bitnomial, while Hyperliquid's offshore operations may face fewer competitors in the short term.

$CBOELow

Analysis: Cboe, Citadel Securities backed group sues CFTC over stock perpetuals

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC to halt perpetual futures trading on individual US stocks, arguing they should be classified as security-based swaps. The CFTC approved the contracts, but the CMA claims they should require SEC registration for retail sales. The lawsuit also questions the CFTC's approval process, which automatically approved the products after 45 days without objection.